PMV Pharmaceuticals Files Proxy Materials

Ticker: PMVP · Form: DEFA14A · Filed: Apr 22, 2026 · CIK: 0001699382

Pmv Pharmaceuticals, Inc. DEFA14A Filing Summary
FieldDetail
CompanyPmv Pharmaceuticals, Inc. (PMVP)
Form TypeDEFA14A
Filed DateApr 22, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-filing, corporate-governance, sec-filing

TL;DR

PMV Pharma filed proxy docs 4/22/26 - check for shareholder votes.

AI Summary

PMV Pharmaceuticals, Inc. filed a DEFA14A on April 22, 2026, related to additional definitive proxy soliciting materials. The filing includes several documents, such as the DEFA14A itself and graphic files, totaling over 3.2 million characters in the complete submission text file. The company's principal office is located at 400 Alexander Park Drive, Suite 301, Princeton, NJ 08540.

Why It Matters

This filing indicates ongoing corporate actions and shareholder communications for PMV Pharmaceuticals, Inc., which could impact investor decisions and company governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain information about significant financial events or strategic shifts.

Key Numbers

  • 3269571 — Complete submission text file size (Indicates the volume of information provided in the filing.)
  • 15463 — DEFA14A document size (Size of the primary proxy statement document.)

Key Players & Entities

  • PMV Pharmaceuticals, Inc. (company) — Filer of the DEFA14A
  • 0001140361-26-016039 (dollar_amount) — SEC Accession Number for the filing
  • 2026-04-22 (dollar_amount) — Filing Date
  • 400 Alexander Park Drive Suite 301 Princeton NJ 08540 (company) — Mailing and Business Address

FAQ

What is the purpose of a DEFA14A filing?

A DEFA14A filing is used for additional definitive proxy soliciting materials and Rule 14(a)(12) material, typically used to provide shareholders with information for upcoming meetings or votes.

When was this DEFA14A filing accepted by the SEC?

The filing was accepted on 2026-04-22 at 08:04:44.

What is the CIK number for PMV Pharmaceuticals, Inc.?

The CIK number for PMV Pharmaceuticals, Inc. is 0001699382.

What is the business address of PMV Pharmaceuticals, Inc.?

The business address is 400 Alexander Park Drive, Suite 301, Princeton, NJ 08540.

What SIC code is associated with PMV Pharmaceuticals, Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 22, 2026 regarding PMV Pharmaceuticals, Inc. (PMVP).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.